Related Experiment Video
Updated: Sep 24, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Machine prescription for chronic migraine.
Anker Stubberud1,2,3, Robert Gray2, Erling Tronvik3,4
1Headache and Facial Pain Group, UCL Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK.
Chronic migraine treatment is complex due to varied patient responses. Advanced modeling reveals diverse underlying causes, leading to a machine prescription policy that significantly reduces time to effective treatment.
Area of Science:
- Neurology
- Computational Biology
- Data Science
Background:
- Chronic migraine poses a significant global disability burden, yet treatment responses vary greatly among individuals.
- The heterogeneity in treatment responsiveness suggests diverse underlying causal mechanisms, complicating effective management.
- Current heuristic approaches to individual treatment evaluation are prolonged and may not identify optimal therapies.
Purpose of the Study:
- To apply complex modeling to large-scale data to understand the heterogeneity of chronic migraine treatment responsiveness.
- To infer the scale of underlying causal diversity in chronic migraine.
- To develop and evaluate a data-driven machine prescription policy for optimizing chronic migraine treatment.
Main Methods:
- Utilized causal multitask Gaussian process models on a cohort of 1446 chronic migraine patients.
- Estimated individual treatment effects for 10 classes of preventative medications.
- Compared treatment response rates between the overall population and subgroups predicted to respond, and evaluated a machine prescription policy against expert guidelines.
Main Results:
- Significantly higher true response rates were observed in individuals modeled to respond compared to the overall population (mean difference 0.034, P=0.033), supporting diverse causal mechanisms.
- The machine prescription policy demonstrated an estimated 35% reduction in time-to-response compared to expert guidelines (P < 0.0001).
- The optimized policy achieved faster treatment success without a substantial increase in patient cost.
Conclusions:
- The complex and distributed causal factors in chronic migraine necessitate high-dimensional modeling for effective management.
- Machine prescription represents a crucial clinical decision-support tool for future chronic migraine treatment strategies.
- Personalized treatment approaches informed by advanced modeling can significantly improve patient outcomes and reduce disability.
Related Concept Videos
Management of Insomnia
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

